Intraventricular administration of antibiotics by ommaya reservoir for patients with multidrug-resistant Acinetobacter baumannii central nervous system infection

References

• Savin I, Ershova K, Kurdyumova N, et al. Healthcare-associated ventriculitis and meningitis in a neuro-ICU: Incidence and risk factors selected by machine learning approach. J Crit Care 2018;45:95–104.
   PubMed Web of Science ®Google Scholar
• Hu F., Guo Y, Yang Y, et al. Resistance reported from China antimicrobial surveillance network (CHINET) in 2018. Eur J Clin Microbiol Infect Dis 2019;38:2275–81.
   PubMed Web of Science ®Google Scholar
• Metan G, Alp E, Aygen B, Sumerkan B. Acinetobacter baumannii meningitis in post-neurosurgical patients: clinical outcome and impact of carbapenem resistance. J Antimicrob Chemother 2007;60:197–9.
   PubMed Web of Science ®Google Scholar
• Levin AS. Multiresistant Acinetobacter infections: a role for sulbactam combinations in overcoming an emerging worldwide problem. Clin Microbiol Infect 2002;8:144–53.
   PubMed Web of Science ®Google Scholar
• Choi JY, Kim CO, Park YS, Yoon HJ, et al. Comparison of efficacy of cefoperazone/sulbactam and imipenem/cilastatin for treatment of Acinetobacter bacteremia. Yonsei Med J 2006;47:63–9.
   PubMed Web of Science ®Google Scholar
• Livermore DM. Tigecycline: what is it, and where should it be used? J Antimicrob Chemother 2005;56:611–4.
   PubMed Web of Science ®Google Scholar
• De Pascale G, Montini L, Pennisi MA, et al. High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria. Crit Care 2014;18:R90.
   PubMed Web of Science ®Google Scholar
• Lee CR, Lee JH, Park M, et al. Biology of Acinetobacter baumannii: pathogenesis, antibiotic resistance mechanisms, and prospective treatment options. Front Cell Infect Microbiol 2017;7:55.
   PubMed Web of Science ®Google Scholar
• Rodvold KA, Gotfried MH, Cwik M, Korth-Bradley JM, Dukart G, Ellis-Grosse EJ. Serum, tissue and body fluid concentrations of tigecycline after a single 100 mg dose. J Antimicrob Chemother 2006;58:1221–9.
   PubMed Web of Science ®Google Scholar
• Nau R, Blei C, Eiffert H. Intrathecal antibacterial and antifungal therapies. Clin Microbiol Rev 2020;33:e00190–19.
   PubMed Web of Science ®Google Scholar
• Wu Y, Chen K, Zhao J, Wang Q, Zhou J. Intraventricular administration of tigecycline for the treatment of multidrug-resistant bacterial meningitis after craniotomy: a case report. J Chemother 2018;30:49–52.
   PubMed Web of Science ®Google Scholar
• Sipahi OR, Mermer S, Demirdal T, et al. Tigecycline in the treatment of multidrug-resistant Acinetobacter baumannii meningitis: results of the Ege study. Clin Neurol Neurosurg 2018;172:31–8.
   PubMed Web of Science ®Google Scholar
• Curebal B, Dalgic N, Bayraktar B. Intraventricular tigecycline for the treatment of shunt infection: a case in pediatrics. J Neurosurg Pediatr 2018;23:247–50.
   PubMed Web of Science ®Google Scholar
• Bhattacharyya S, Darby RR, Raibagkar P, Castro LN, Berkowitz AL. Antibiotic-associated encephalopathy. Neurology 2016;86:963–71.
   PubMed Web of Science ®Google Scholar
• Fried HI, Nathan BR, Rowe AS, et al. The insertion and management of external ventricular drains: an evidence-based consensus statement: a statement for healthcare professionals from the Neurocritical Care Society. Neurocrit Care 2016;24:61–81.
   PubMed Web of Science ®Google Scholar
• Ye J, Tan LH, Shen ZP, et al. Polymyxin for the treatment of intracranial infections of extensively drug-resistant bacteria in children after neurosurgical operation. World Journal of Pediatrics 2020; Mar 19:1–5. Online ahead of print. doi: 10.1007/s12519-020-00350-8
   PubMed Web of Science ®Google Scholar
• Chen F, Deng X, Wang Z, Wang L, Wang K, Gao L. Treatment of severe ventriculitis caused by extensively drug-resistant Acinetobacter baumannii by intraventricular lavage and administration of colistin. Infect Drug Resist 2019;12:241–7.
   PubMed Web of Science ®Google Scholar
• Ommaya A. Subcutaneous reservoir and pump for sterile access to ventricular cerebrospinal fluid. Lancet 1963;282:983–4.
   Google Scholar
• Lau JC, Kosteniuk SE, Macdonald DR, Megyesi JF. Image-guided ommaya reservoir insertion for intraventricular chemotherapy: a retrospective series. Acta Neurochir (Wien) 2018;160:539–44.
   PubMed Web of Science ®Google Scholar
• Nakama T, Yamashita S, Hirahara T, et al. Usefulness of intraventricular infusion of antifungal drugs through ommaya reservoirs for cryptococcal meningitis treatment. J Neurol Sci 2015;358:259–62.
   PubMed Web of Science ®Google Scholar
• Lin J, Zhou H, Zhang N, Yin B, Sheng HS. Effects of the implantation of ommaya reservoir in children with tuberculous meningitis hydrocephalus: a preliminary study. Childs Nerv Syst 2012;28:1003–8.
   PubMed Web of Science ®Google Scholar
• Lau JC, Kosteniuk SE, Walker T, Iansavichene A, Macdonald DR, Megyesi JF. Operative complications with and without image guidance: a systematic review and meta-analysis of the ommaya reservoir literature. World Neurosurg 2019;122:404–14.
   PubMed Web of Science ®Google Scholar
• Korinek AM, Reina M, Boch AL, Rivera AO, De Bels D, Puybasset L. Prevention of external ventricular drain-related ventriculitis. Acta Neurochir 2005;147:39–46.
   PubMed Web of Science ®Google Scholar